David Folkenflik

You know, if you have a drug that is going to help you fight your cancer, put you in remission or potentially cure your cancer, of course, you know, anybody would do whatever they could to get that paid for.

You know, if you have a drug that is going to help you fight your cancer, put you in remission or potentially cure your cancer, of course, you know, anybody would do whatever they could to get that paid for.

You know, if you have a drug that is going to help you fight your cancer, put you in remission or potentially cure your cancer, of course, you know, anybody would do whatever they could to get that paid for.

Patients who have different health plans with high co-pays or large out-of-pocket costs, who can't find another way to get that covered, they've really suffered. I've talked to patients who stopped taking the drug for a period of time because it was not financially possible for them. Or, you know, raided retirement funds, took out a mortgage, skimped on other things like groceries even.

Patients who have different health plans with high co-pays or large out-of-pocket costs, who can't find another way to get that covered, they've really suffered. I've talked to patients who stopped taking the drug for a period of time because it was not financially possible for them. Or, you know, raided retirement funds, took out a mortgage, skimped on other things like groceries even.

Patients who have different health plans with high co-pays or large out-of-pocket costs, who can't find another way to get that covered, they've really suffered. I've talked to patients who stopped taking the drug for a period of time because it was not financially possible for them. Or, you know, raided retirement funds, took out a mortgage, skimped on other things like groceries even.

The problem becomes, how do you make this happen? What's the mechanism here? Medicare recently has been allowed through the Inflation Reduction Act, very limited drug negotiating powers, 10 drugs in the first year, okay? The reaction of the pharmaceutical industry was to file lawsuit after lawsuit. There's pending litigation here.

The problem becomes, how do you make this happen? What's the mechanism here? Medicare recently has been allowed through the Inflation Reduction Act, very limited drug negotiating powers, 10 drugs in the first year, okay? The reaction of the pharmaceutical industry was to file lawsuit after lawsuit. There's pending litigation here.

The problem becomes, how do you make this happen? What's the mechanism here? Medicare recently has been allowed through the Inflation Reduction Act, very limited drug negotiating powers, 10 drugs in the first year, okay? The reaction of the pharmaceutical industry was to file lawsuit after lawsuit. There's pending litigation here.

I just don't see where they're gonna agree to this in any way without a fight.

I just don't see where they're gonna agree to this in any way without a fight.

I just don't see where they're gonna agree to this in any way without a fight.

Venomous snakebites aren't often at the top of the global health agenda. But each year, millions of people get bitten, often far away from antivenom treatment. To raise awareness, a new initiative called Strike Out Snakebite scattered human-sized snake statues throughout Geneva.

Venomous snakebites aren't often at the top of the global health agenda. But each year, millions of people get bitten, often far away from antivenom treatment. To raise awareness, a new initiative called Strike Out Snakebite scattered human-sized snake statues throughout Geneva.

That's David Lalu, vice chancellor of the Liverpool School of Tropical Medicine. Going forward, he says the initiative aims to boost funding for anti-venom research and help bolster health systems so they can get bitten people to treatment before it's too late. Jonathan Lambert, NPR News.

That's David Lalu, vice chancellor of the Liverpool School of Tropical Medicine. Going forward, he says the initiative aims to boost funding for anti-venom research and help bolster health systems so they can get bitten people to treatment before it's too late. Jonathan Lambert, NPR News.

There's been a lot of misinformation about this and indicating that it's compulsory and so forth, and it's not. It's purely voluntary, and we've protected the rights of those that choose not to participate.

There's been a lot of misinformation about this and indicating that it's compulsory and so forth, and it's not. It's purely voluntary, and we've protected the rights of those that choose not to participate.

It's not clear he has the power to do this. The Corporation for Public Broadcasting has filed a suit in court that's supposed to move forward next week. It's being heard on an expedited basis by a federal judge in Washington. And we're going to see. It appears right now that the CPB is simply ignoring the president's edict, saying he doesn't have the authority to do this.

It's not clear he has the power to do this. The Corporation for Public Broadcasting has filed a suit in court that's supposed to move forward next week. It's being heard on an expedited basis by a federal judge in Washington. And we're going to see. It appears right now that the CPB is simply ignoring the president's edict, saying he doesn't have the authority to do this.